Business News/Market/Market Stats/   Ajanta Pharmaceuticals share price
Mutual Fund Ownership
Ownership as on: Wed, 4 Oct, 2023

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)41.46
% of AUM5.34%

Samco Active Momentum Fund Regular Growth

NA
Equity
Amount Invested (Cr.)17.34
% of AUM4.07%

Samco ELSS Tax Saver Fund Regular Growth

NA
Equity
Amount Invested (Cr.)1.91
% of AUM3.10%

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)167.25
% of AUM3.02%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)16.52
% of AUM2.51%

Ajanta Pharmaceuticals SUMMARY

Ajanta Pharmaceuticals is trading -0.70% lower at Rs 1,776.85 as compared to its last closing price. Ajanta Pharmaceuticals has been trading in the price range of 1,793.40 & 1,776.85. Ajanta Pharmaceuticals has given 49.14% in this year & 6.57% in the last 5 days.

 

Ajanta Pharmaceuticals has TTM P/E ratio 30.05 as compared to the sector P/E of 21.97.

 

The company posted a net profit of 208.12 Crores in its last quarter.

 

Listed peers of Ajanta Pharmaceuticals include IPCA Laboratories (-0.88%), JB Chemicals & Pharmaceuticals (0.01%), Ajanta Pharmaceuticals (-0.70%) etc.

FAQs about Ajanta Pharmaceuticals share price

Ajanta Pharmaceuticals is trading at 1776.85 as on Wed Oct 04 2023 06:02:43. This is -0.70% lower as compared to its previous closing price of 1789.40.

The market capitalization of Ajanta Pharmaceuticals is 22373.32 Cr as on Wed Oct 04 2023 06:02:43.

The 52 wk high for Ajanta Pharmaceuticals is 1903.85 whereas the 52 wk low is 1105.46

Ajanta Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 30.05
  • Sector P/E: 21.97
  • Dividend Yield: 0.95%
  • D/E ratio: -

Ajanta Pharmaceuticals reported a net profit of 587.98 Cr in 2023.

Recommended For You
Trending Stocks
22,658.85+320.70(1.44%)
1,520.35+12.40(0.82%)
3,182.60+16.00(0.51%)
1,011.00-29.00 (-2.79%)
1,397.50-38.15 (-2.66%)